Recently diagnosed with HIV? Click here

First-line therapy

Displayed below is content from the NAPWA website tagged with the keyword first-line therapy.

Abacavir or tenofovir for first-line?

Positive Living article • Graham Stocks • 24 November 2011

According to the Canadian Observational CohortIn epidemiologyThe branch of medical science that deals with the study of incidence and distribution and control of a disease in a population., a group of individuals with some characteristics in common. A cohort study is a special kind of clinical trialA clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. which looks at a treatment or treatment strategy in a cohort of people. collaboration, abacavir (ABC) or tenofovir (TDF) are equally effective in first-line treatment.

The authors found that in their group of treatment-naive patients starting treatment, there was no difference in time to suppression with ABC/3TC (Kivexa) versus TDF/FTC (Truvada). read more »

Raltegravir approved for first line

Positive Living article • Adrian Ogier • 3 September 2010

The Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. (PBS) has broadened access to raltegravir (Isentress) beyond treatment-experienced adults.

Raltegravir is now also available for people who are first starting HIV treatment.

Raltegravir + Truvada is now one of four preferred commencing regimens in the Australian HIV Treatment Guidelines. read more »

What's Your Problem?

Positive Living article • Dr Louise Owen • 5 June 2009

Doctor Louise Owen answers readers’ questions. This month: starting antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatment and lipodystrophy. read more »

Syndicate content
Text size: font smallerfont normalfont larger

Stay in touch

NAPWA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWA's work and be alerted to new content on the website by following @napwa.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.